This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Oct 28;354(6311):419-420.

doi: 10.1126/science.aak9776.

Warburg meets epigenetics

Chirag H Patel¹, Jonathan D Powell²

Affiliations

Affiliations

¹ Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Immunology CRB I Rm 443, Baltimore, MD 21287, USA.
² Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Immunology CRB I Rm 443, Baltimore, MD 21287, USA. poweljo@jhmi.edu.

PMID: 27789830
DOI: 10.1126/science.aak9776

Comment

Warburg meets epigenetics

Chirag H Patel et al. Science. 2016.

. 2016 Oct 28;354(6311):419-420.

doi: 10.1126/science.aak9776.

Authors

Chirag H Patel¹, Jonathan D Powell²

Affiliations

¹ Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Immunology CRB I Rm 443, Baltimore, MD 21287, USA.
² Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Immunology CRB I Rm 443, Baltimore, MD 21287, USA. poweljo@jhmi.edu.

PMID: 27789830
DOI: 10.1126/science.aak9776

No abstract available

PubMed Disclaimer

Comment on

Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism.
Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Peng M, et al. Science. 2016 Oct 28;354(6311):481-484. doi: 10.1126/science.aaf6284. Epub 2016 Sep 29. Science. 2016. PMID: 27708054 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Grants and funding

T32 AI007247/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations